NCT05150847 is a NA clinical trial of Oxygenation in Coronavirus Disease 2019, sponsored by Tepecik Training and Research Hospital.

Who is sponsoring NCT05150847?

NCT05150847 is sponsored by Tepecik Training and Research Hospital.

What drugs are being tested in NCT05150847?

Interventions in NCT05150847: Oxygenation.

What condition does NCT05150847 study?

NCT05150847 studies Coronavirus Disease 2019, ARDS, Mechanical Ventilation Pressure High.

Is NCT05150847 still recruiting?

NCT05150847 is currently status unknown. Last updated 1 February 2022.

Last reviewed 2022-02-01 · How we verify

NCT05150847

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prone Positioning in COVID-19 Patients

Status unknown NA Last updated 1 February 2022

What this trial tests

NA trial testing Oxygenation in Coronavirus Disease 2019 in 50 participants. Status unknown.

Timeline

25 December 2021

Primary endpoint
1 February 2022

13 April 2022

Quick facts

Lead sponsor	Tepecik Training and Research Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	50
Start date	25 December 2021
Primary completion	1 February 2022
Estimated completion	13 April 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Oxygenation

Conditions studied

Coronavirus Disease 2019 — all drugs for Coronavirus Disease 2019 →
ARDS — all drugs for ARDS →
Mechanical Ventilation Pressure High — all drugs for Mechanical Ventilation Pressure High →

Sponsor

Tepecik Training and Research Hospital

Who can join

18 and older, any sex, with Coronavirus Disease 2019 or ARDS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prone positioning improves oxygenation in patients with ARDS (1-3). Patients with severe ARDS due to COVID-19 are candidates for prone position. It should be started within 36-48 h and maintained 1, 3). Prone ventilationARDS based on a randomized trial that showed a mortality benefit (PROSEVA) (3). The improvement of oxygenation occurs by making ventilation more homogeneous, limiting ventilator-associated lung injury (4-6). Prone positioning was as effective in improving oxygenation, static respiratory system compliance (Crs) (7). Higher PEEP should be applied when there is a high recruitability potential of the lung. This study aimed to investigate whether prone positioning changes the recruitability position of the lung.in COVID-ARDS.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of the prone position on recruitability in acute respiratory distress syndrome due to COVID-19 pneumonia.
Emgin Ö, Rollas K, Yeniay H, Elve R, et al · · 2023 · cited 2× · PMID 37222316 · DOI 10.1590/1806-9282.20221120

Verify or expand the search:

Other trials of Oxygenation

Trials testing the same drug.

NCT03571074 — Hyperoxia Before and After Cardiac Arrest and Myocardial Damage · completed

Other recruiting trials for Coronavirus Disease 2019

Currently open trials in the same condition.

NCT05160636 — A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza · active not recruiting
NCT05164744 — Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors · recruiting

Other Tepecik Training and Research Hospital trials

Trials by the same sponsor.

NCT07533916 — ICU Environmental Noise and Healthcare Workers · completed
NCT07526467 — Video-EEG Semiological Patterns in PNES · completed
NCT07299708 — Effects of Sleep Quality, Anxiety, and Digital Behavior on Labor Progression in Term Primiparous Women: A Prospective Ob · completed
NCT06563830 — Prevent Medical Device-Related Pressure Injury · NA · not yet recruiting
NCT05946291 — Simulation Applications on the Level of Pressure Injury Knowledge and Evaluation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05150847 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tepecik Training and Research Hospital
Last refreshed: 1 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05150847.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing